IP Library Assignment 060529/0195
Patent Assignment
Reel/Frame 060529/0195

Assignment of Assignor's Interest

Recorded: 2022-07-18 Pages: 7
Assignor
CELL MEDICA INC.
Executed: 2022-06-09
Assignee
CELL MEDICA, INC.
2617 BISSONNET ST, SUITE 300, HOUSTON, TEXAS, 77005
Covered Properties (24)
Binding Members to Pd-L1
Application: 16/079,210 →
Publication: US US20190055312A1
Modified Cells for Immunotherapy
Application: 16/079,202 →
Publication: US US20190048085A1
Antibodies Against Il-1 Beta
Patent: 9,914,772 →
Application: 14/740,434 →
Publication: US US20160194392A1
Antibodies Against Il-1 Beta
Application: 15/896,309 →
Publication: US US20180258165A1
Antibody to Human Il-1 Beta
Patent: 9,404,930 →
Application: 14/072,165 →
Publication: US US20140134183A1
Method of Inhibiting Human Il-1 Beta by Administering an Antibody to Human Il-1 Beta
Application: 15/202,982 →
Publication: US US20170051054A1
Nucleic Acid Encoding Antibody to Human Il-1 Beta
Application: 16/118,124 →
Publication: US US20180362642A1
Antibody to Human Il-1 Beta
Application: 16/822,952 →
Publication: US US20200239565A1
Tnf Alpha Antibody or Fragment Thereof and Methods of Use
Application: 15/127,976 →
Publication: US US20170107282A1
Nucleic Acids Encoding Binding Members to Tnf Alpha
Application: 16/258,886 →
Publication: US US20190144532A1
Acceptor Framework for Cdr Grafting
Patent: 8,399,624 →
Application: 12/823,488 →
Acceptor Framework for Cdr Grafting
Patent: 9,051,366 →
Application: 13/765,326 →
Publication: US US20130165640A1
Acceptor Framework for Cdr Grafting
Patent: 9,403,903 →
Application: 14/706,484 →
Publication: US US20150315294A1
Acceptor Framework for Cdr Grafting
Patent: 9,994,645 →
Application: 15/193,432 →
Publication: US US20160347864A1
Acceptor Framework for Cdr Grafting
Patent: 8,399,625 →
Application: 12/823,551 →
Acceptor Framework for Cdr Grafting
Patent: 9,005,924 →
Application: 13/765,302 →
Publication: US US20130165639A1
Acceptor Framework for Cdr Grafting
Patent: 9,409,979 →
Application: 14/644,441 →
Publication: US US20150232543A1
Acceptor Framework for Cdr Grafting
Application: 15/195,411 →
Publication: US US20160304627A1
Acceptor Framework for CDR Grafting
Application: 16/879,978 →
Publication: US US20200362059A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,067,547 →
Application: 11/916,793 →
Publication: US US20090263382A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,389,693 →
Application: 13/245,420 →
Publication: US US20120064077A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 8,691,228 →
Application: 13/708,500 →
Publication: US US20130171143A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,315,572 →
Application: 14/185,783 →
Publication: US US20140171634A1
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Patent: 9,683,034 →
Application: 15/064,067 →
Publication: US US20160185850A1
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 2, 2010
From: ESCHER, DOMINIK
To: ALCON RESEARCH, LTD.
Reel/Frame 024931/0219 →
Assignment of Assignor's Interest Sep 2, 2010
From: ESCHER, DOMINIK
To: A
Reel/Frame 024931/0374 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 024931 Frame 0219. Assignor(S) Hereby Confirms the Esbatech, an Alcon Biomedical Research Unit Llc. Sep 25, 2010
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 025042/0863 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 024931 Frame 0374. Assignor(S) Hereby Confirms the Esbatech, an Alcon Biomedical Research Unit Llc. Sep 25, 2010
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 025042/0843 →
Assignment of Assignor's Interest Jan 21, 2014
From: GRABULOVSKI, STEFANIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 032012/0158 →
Assignment of Assignor's Interest Oct 22, 2015
From: HONEGGER, ANNEMARIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 036854/0706 →
Change of Name Aug 8, 2016
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 039629/0573 →
Assignment of Assignor's Interest Oct 20, 2016
From: KRETZSCHMAR, TITUS
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 040078/0694 →
Assignment of Assignor's Interest Oct 20, 2016
From: SHAMSHIEV, ABDIJAPAR
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 040078/0622 →
Assignment of Assignor's Interest Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
Security Interest Jul 7, 2021
From: CELL MEDICA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056782/0954 →
Assignment of Assignor's Interest Apr 10, 2022
From: HONEGGER, ANNEMARIE; KRETZSCHMAR, TITUS; SCHMITT, SIMONE; SHAMSHIEV, ABDIJAPAR
To: DELENEX THERAPEUTICS AG
Reel/Frame 059552/0839 →
Assignment of Assignor's Interest Apr 10, 2022
From: ESBATECH, A NOVARTIS COMPANY LLC
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 059553/0144 →
Assignment of Assignor's Interest Apr 10, 2022
From: ESCHER, DOMINIK
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 059553/0097 →
Change of Name Apr 10, 2022
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 059552/0850 →
Change of Name Jul 18, 2022
From: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
To: ESBATECH, A NOVARTIS COMPANY LLC
Reel/Frame 060529/0545 →